IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

Actavis Acquires Chinese Manufacturer

12:27 PM MDT | April 18, 2008 | DR

Generics pharmaceutical manufacturer, Actavis (Hafnarfjordur, Iceland) says it has acquired 90% of active pharma ingredient (API) producer Zhejiang Chiral Medicine Chemicals Co. (Hangzhou, China). Terms of the deal were not disclosed. Actavis says the acquisition is part of its strategy to obtain direct access to low-cost API manufacturing. Wessman: Access to low-cost production. “This new facility will enable Actavis to further reduce its manufacturing costs and is an important extension of our activities in China,” says Robert Wessman, president and...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa